cancer clinical trials for Breast (ONC)

16 Breast (ONC) clinical trials found. View a list of all cancer clinical trial types.

• Phase II trial to evaluate immune-related biomarkers for pathological response in stage II-III HER2-positive breast cancer receiving neoadjuvant chemotherapy with subsequent randomization to multi-epitope HER2 vaccine vs. placebo in patients with residual disease post-neoadjuvant chemotherapy

  Current Status: Open

  View links and contact information related to this clinical trial

• The Utility of Enhanced Recovery After Surgery (ERAS) Protocols in Breast Conserving Surgery: A Randomized Control Trial

  Current Status: Open

  View links and contact information related to this clinical trial

• LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients With Molecular Low-Risk Early-Stage Breast Cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy

  Current Status: Open

  View links and contact information related to this clinical trial

• Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT)

  Current Status: Open

  View links and contact information related to this clinical trial

• Integrating eHealth and Lay Navigation to Optimize Treatment Initiation and Adherence (REALIZ) among Black Women with Breast Cancer: A Pilot Implementation Feasibility Study

  Current Status: Open

  View links and contact information related to this clinical trial

• A phase II clinical trial assessing the safety of neoadjuvant palbociclib in combination with endocrine therapy for post and pre-menopausal patients with early stage hormone receptor positive and Her-2/neu negative breast cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• Evaluation of Gut Microbiome Diversity in Breast Cancer Survivors Following Active Cancer Therapy

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized, Multicenter, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects With Residual Disease or High-Risk PCR After Both Neoadjuvant and Postoperative Adjuvant Trastuzumab-based Therapy (FLAMINGO-01)

  Current Status: Open

  View links and contact information related to this clinical trial

• ESTABLISHMENT OF A NATIONAL BIOREPOSITORY TO ADVANCE STUDIES OF IMMUNE-RELATED ADVERSE EVENTS

  Current Status: Open

  View links and contact information related to this clinical trial

• Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized Study Evaluating GLIADEL Compared to Stereotactic Radiosurgery in Patients with Metastatic Brain Disease

  Current Status: Open

  View links and contact information related to this clinical trial

• Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study

  Current Status: Open

  View links and contact information related to this clinical trial

• Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase I, Dose Escalation and Dose Expansion, Safety and Tolerability Study of onCARlytics (CF33-CD19), Administered Intravenously or Intratumorally in Combination with Blinatumomab in Adults with Advanced or Metastatic Solid Tumors

  Current Status: Not Open

  View links and contact information related to this clinical trial